ITMCTR2026001718进行中（未招募）Unknown
The Additional Effect of Baduanjin on Improving the Quality of Life in Menopausal Women
Women's Hospital, School of Medicine, Zhejiang University0 个研究点开始时间: 2026年7月15日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 45 至 55（—）
- 性别
- Female
入选标准
- •Women aged =45 years with prominent menopausal symptoms and impaired quality of life (Kupperman Menopausal Index score > 6 points).
排除标准
- •Regular use of hormone replacement therapy or high-dose phytoestrogen supplements within the past month; presence of severe physical illness, severe osteoarthritis or limited motor function that prevents safe and independent completion of Baduanjin exercises; diagnosis of severe mental disorders (e.g., major depressive disorder, schizophrenia).
研究者
相似试验
进行中（未招募）
不适用
Evaluation of Bojungikgi-tang for fatigue accompanied by persistent allergic rhinitisDiseases of the respiratory systemKCT0012281Daejeon University128
已完成
1 期
A research study comparing the effect of different dosing conditions on blood levels of semaglutide in a new tablet composition in healthy participantsType 2 Diabetes2023-503949-65-00Novo Nordisk A/S120
尚未招募
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared with Placebo in Adults with Type 2 Diabetes Mellitus on
Background Insulin (Eluminate-3)Type 2 Diabetes MellitusjRCT203126026280
招募中
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron and Dapagliflozin in Combination, Compared With Elecoglipron Alone and Dapagliflozin Alone, in Adults With Type 2 Diabetes Mellitus (Eluminate-5)Type 2 Diabetes MellitusjRCT2031260261165
招募中
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin (Eluminate-4)Type 2 Diabetes Mellitus and Impaired Renal FunctionjRCT2031260268118